ANIK Stock Analysis: Buy, Sell, or Hold?
ANIK - Anika Therapeutics Inc
$9.23
0.08 (0.87%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 11, 2026
Get Alerted When ANIK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ANIK shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ANIK shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$9.11
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$5.66
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ANIK is currently trading at $9.23, which is considered oversold relative to its 30-day fair value range of $9.28 to $9.60. The stock's valuation (Forward PE: 35.2) is in line with its historical norms (36.9). Remarkably, the market is currently pricing in an annual earnings decline of 1.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ANIK is in a uptrend. The price is currently testing key support at $9.01. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ANIK has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $16.00 (+74.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ANIK is in a uptrend. The price is currently testing key support at $9.01. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ANIK has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $16.00 (+74.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$9.28 -
$9.60
Company Quality Score
54/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
59.6%
Protect Your Profits
Holding ANIK? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 74.9% below Wall St target ($16.00)
Fair Price Analysis
30-Day Fair Range
$9.28 -
$9.60
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.81
(8.8%)
Support & Resistance Levels
Support Level
$9.01
Resistance Level
$9.60
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
35.19
Wall Street Target
$16.00
(+74.9%)
Revenue Growth (YoY)
-5.9%
Earnings Growth (YoY)
-50.5%
Profit Margin
-29.3%
Valuation Discount vs History
-1.5% cheaper
PE vs Historical
35.2 vs 36.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.5%
(market-implied from PE analysis)
1-Year Target
$9.01
(-2%)
2-Year Target
$8.88
(-3%)
3-Year Target
$8.74
(-4%)
3-Yr Target (if PE normalizes)
(PE: 35→37)
$9.17
(+0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 35.2 to 36.9
Stabilization Target:
$9.59
(+4.9%)
PE Expansion Potential:
+4.9%
Last updated: January 30, 2026 11:32 PM ET
Data refreshes hourly during market hours. Next update: 12:32 AM
Data refreshes hourly during market hours. Next update: 12:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ANIK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$179 | 62 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$158 | 56 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$84 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 57 HOLD |
Advanced ANIK Option Strategies
Professional options setups generated by AI based on today's ANIK price and gamma walls.
